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Summary.-Ovarian function was studied in 18 female patients treated for ab-
dominal tumours during childhood. All received abdominal radiotherapy as part
of their treatment and were studied between 1 and 26 years after irradiation. The
serum gonadotrophins and oestradiol levels were consistent with ovarian failure
in each case but there was a disproportionate elevation in serum follicle stimulating
hormone (FSH) when compared to serum luteinizing hormone (LH) in 16. In 2
patients, the radiotherapeutic field extended downwards only as far as the sacral
promontory. However, these 2 girls show similar evidence of ovarian failure to
that in the other 16.
RADIOTHERAPY is an accepted method
of inducing an artificial menopause. Doll
and Smith (1968) found that 9700 of 2068
women failed to menstruate again after
an estimated ovarian dose of 360-720 rad
given in 1, 2 or 3 fractions. There is,
however, a paucity of data concerning
ovarian function following abdominal irra-
diation in childhood. Pearson, Duncan
and Pointon (1964) observed 3 out of 5
girls who, having received abdominal
irradiation for nephroblastoma, later pre-
sented with primary amenorrhoea. Un-
fortunately no endocrine data were avail-
able in these cases. We therefore decided
to examine ovarian function in patients
who had received irradiation for ab-
dominal lesions during childhood.
PATIENTS AND METHODS
Eighteen female patients who, in child-
hood, had received treatment for abdominal
lesions, were studied. There were 13 cases
of nephroblastoma, 3 of neuroblastoma,
1 of rhabdomyosarcoma bladder and 1 of
reticulo-endothelial disease of uncertain hist-
ology. All 18 had abdominal surgery and
irradiation, and 7 had chemotherapy. Only
2 patients (subjects No. 7 and 9) were still
receiving cytotoxic agents at the time of
the study. The dose of abdominal irradia-
tion ranged from 2000-3000 rad over 25-44
days. In 16 cases the whole abdomen,
including the pelvis, was irradiated. In 2
cases (subjects No. 7 and 12), however, the
radiation zone was restricted to above the
level of the sacral promontory.
Serum FSH and LH levels were measured
by double antibody radioimmunoassay using
Medical Research Council standard 69/104.
Serum oestradiol was measured by radio-
immunoassay as published elsewhere (Eng-
land et al., 1974). Serum assays were done
on venous blood samples collected at routine
clinical visits.
Subject No. 1 was the only patient to
have taken oestrogens prior to the study.
The last tablet was taken 6 weeks previously,
and cyclical hormonal therapy restarted after
the blood samples had been taken.
Statistical significance of the results was
evaluated using the Mann-Whitney U test
(Siegel, 1956).
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TABLE.-Clinical and Hormonal Data
Patient Diagnosis
1 Nephroblastoma
2 Nephroblastoma
3 Nephroblastoma
4 Nephroblastoma
5 Nephroblastoma
6 Rhabdomyo-
sarcoma
bladder
7 Nephroblastoma
8 Nephroblastoma
9 Neuroblastoma
10 Nephroblastoma
11 Nephroblastoma
12 Nepliroblastoma
13 -Nephroblastoma
14 Neuroblastoma
15 Nephroblastoma
16 Neuroblastoma
17 Reticulo-
endothelial
disease
18 Nephroblastoma
Age at
treat-
ment
(years)
7
5
4
1
3
4
Abdominal
dose
(rad and
duration)
3000 (37 days)
2500 (37 days)
2500 (38 days)
2530 (38 days)
2730 (41 days)
3000 (35 days)
13 3000 (27 days)
3 3000 (35 days)
13 2700 (25 days)
2
7
3
1
1
5
1
2
3000 (35 days)
3000 (27 days)
3000 (27 days)
2770 (38 days)
2500 (44 days)
2500 (35 days)
2500 (33 days)
2000 (30 days)
1 2500 (36 days)
Chemotherapy
Actinomycin D
Actinomycin D
Actinomycin D+
Vincristine
Actinomycin D
Vincristine+
Cyclophosphamide
Actinomycin D
Actinomycin D
11 7 75 24
In subjects 1-13 the basal gonadotrophins were measured at the Bolton Royal Infirmary.
Normal range for prepubertal female: FSH 0-3 iu/l, LH 0-2 iu/l.
Normal range for adult female (follicular phase): FSH 1-8 iu/l, LH 1-7 iu/l.
In subjects 14-18 the basal gonadotrophins were measured at the Royal Postgraduate Medical School.
Normal range for adult female (follicular phase): FSH 2-8- 2 iu/1, LH 3 6-9 0 iu/l.
Normal range for serum oestradiol in prepubertal girls: 0-40 pg/ml.
Mean concentration for serum oestradiol in adult women (follicular phase): 35 3 ± 4-39 (s.e. mean)
pg/ml.
Mean concentration for serum oestradiol in adult women (ovulatory peak): 192 9 ± 12 7 (s.e. mean)
pg/ml.
Mean concentration for serum oestradiol in adult women (luteal phase): 67-3 ± 1-47 (se mean) pg/ml.
RESULTS
The mean age at menarche in the
United Kingdom is 13-4years (Marshall
and Tanner, 1969). Twelve of the 18
patients shown in the table are aged 13
years or over and none ofthem is currently
menstruating. However, in subjects No.
7 and 9 menarche had occurred before
their treatment but amenorrhoea ensued
within 2 months of completing the course
ofabdominal irradiation. The basal serum
FSH and LH levels are considerably
elevated in all 12 girls.
The serum FSH concentration is
markedly raised in all 6 patients below
the age of 13 years, whereas the serum
LH is only elevated in 3 of these. The
figure shows serum LH levels in subjects
No. 1 to 13 expressed against the age
of the patient. It can be seen that the
serum LH levels are considerably higher
in the 8 patients aged over 11 years than
the 5 patients aged 11 years or less. The
difference between these two groups is
significant (P > 002).
The serum oestradiol levels in all
subjects are within the normal pre-
pubertal range.
DISCUSSION
The combination of elevated basal
serum gonadotrophins and low serum
oestradiol levels confirms the clinical
diagnosis of ovarian failure in the patients
described in this study.
Cytotoxic drugs such as cyclophos-
Age at
study
(years)
33
21
13
15
14
9
14
11
14
9
10
11
13
14
17
18
13
Serum
oestra-
diol
(pg/ml)
18
25
0
8
2
2
0
35
10
36
15
36
18
2
2
5
0
Serum
FSH
(iu/l)
42
>50
>50
>50
>50
>50
>25
40
>50
40
15
>50
>50
>100
>100
90
128
Serum
LH
(iu/l)
34
25
>50
24
35
8
21
1
>50
1
2
32
31
18
38
27
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FIGUIRE. Basal serum LH in Subjects Nos. 1-13 correlated with age in years.
phamide are known to cause amenorrhoea
(Kumar et al., 1972) and, in some in-
stances, ovarian fibrosis (Millar, Williams
and Leissring, 1971). However, only 1
girl in this group received cyclophospham-
ide and only 2 girls were currently being
treated with chemotherapeutic agents at
the time of the study. There is no
difference between the endocrine profile
in these girls and the rest of the group
not treated with drugs.
In these 18 patients, the probable
cause of the ovarian failure is abdominal
irradiation, with chemotherapy potenti-
ally an additional factor in a minority.
The serum FSH level was raised in
all 18 patients whilst the serum LH level
was raised in 15. Furthermore, the
serum FSH shows a more marked eleva-
tion than the serum LH in 16 patients,
with the data in the remaining 2 patients
not sufficiently detailed to allow this
distinction to be detected.
This disproportionate elevation of
serum FSH as compared to serum LH
is similar to that described in gonadal
dysgenesis (Penny et al., 1970). This
suggests that despite marked differences
in the pathogenesis of ovarian failure,
the qualitative gonadotrophin response is
identical.
Conte, Grumbach and Kaplan (1975)
observed a sharp increase of serum
gonadotrophin levels in patients with
gonadal dysgenesis from the age of 11
years, while Job et al. (1974) noted
similar findings from the age of 12 years.
We can only provide further data on
the serum LH changes, which show a
similar increase from the age of 11 years
onwards. This confirms that the pattern
of gonadotrophin regulation changes at
around the age of 11-12 years in girls
with ovarian failure, just as is seen in
normal subjects.
Ovarian failure following abdominal
irradiation is not always a permanent
defect. Baker et al. (1972) described
one woman who received pelvic irradiation
for Hodgkin's disease followed by 2
years' amenorrhoea, then irregular men-
struation, and finally the birth of a
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normal child 6 years later. Consequently
we were encouraged to learn that subject
No. 3 had her first period 4 months after
our tests had confirmed ovarian failure.
However, she has had no subsequent
periods for 3 months and continues to
have very high basal gonadotrophins and
low serum oestradiol levels. Sherman
and Korenman (1975) observed similar
hormonal patterns in perimenopausal
women, many of whom had irregular,.
anovulatory cycles, and presumably the
isolated period ofsubjectNo. 3represented
a similar phenomenon. Our patients
were studied between 1 and 26 years
after irradiation and there must be
very little hope of ovarian recovery in the
majority of them.
The main pathological diagnosis in
this group ofpatients wasnephroblastoma,
which represents approximately 8% of
all childhood malignancy (Ledlie et al.,
1970). There has been a considerable
improvement in the cure rate of this
tumour after the addition of cyclic
chemotherapy to surgery and irradiation.
Thus, the 2-year cure rate, for patients
who presented with localized abdominal
disease, has risen to 80%.
As abdominal irradiation is used by
some in the management of the various
stages of this disease, results should be
assessed with reference to the sequelae
detailed in this paper. It should be
noted that our 2 patients (subjects No. 7
and 12) who received abdominal irradia-
tion with a field which extended down
only as far as the sacral promontory
show a similar hormonal pattern of
ovarian failure to that seen in the other
16 cases. This suggests that if ovarian
function is to be preserved then the
lower limit of the radiation field will need
to be raised.
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